Tom Martin (@tombmt133) 's Twitter Profile
Tom Martin

@tombmt133

Associate Chief Hematology, Director- Blood and Marrow Transplant,

ID: 812851718014701568

calendar_today25-12-2016 02:45:26

205 Tweet

2,2K Followers

152 Following

Tom Martin (@tombmt133) 's Twitter Profile Photo

Amazing - Bruno Pavia presenting CTCs and their importance in defining HR-SMM at the Asian Myeloma Network Summit Bangkok 2023 - more to come at ASH

Amazing - Bruno Pavia presenting CTCs and their importance in defining HR-SMM at the Asian Myeloma Network Summit Bangkok 2023 - more to come at ASH
Multiple Myeloma Hub (@mm_hub) 's Twitter Profile Photo

CONGRESS #EHA2024 | Thierry Facon Université de Lille presents findings of the phase III IMROZ study (NCT03319667), evaluating efficacy and safety of Isa-VRd vs VRd in transplant-ineligible pts with NDMM (N=446). The study met its primary endpoint: 60-mo PFS rate was 63.2% with Isa-VRd

CONGRESS #EHA2024 | <a href="/ThierryFacon/">Thierry Facon</a> <a href="/univ_lille/">Université de Lille</a> presents findings of the phase III IMROZ study (NCT03319667), evaluating efficacy and safety of Isa-VRd vs VRd in transplant-ineligible pts with NDMM (N=446). The study met its primary endpoint: 60-mo PFS rate was 63.2% with Isa-VRd
Binod Dhakal (@bhemato) 's Twitter Profile Photo

Next generation CAR with novel binding domain! Deep and durable response in high risk patients! Look forward to getting this to our patients! ⁦MCW Cancer Center⁩ ⁦European Hematology Association⁩ #eha2024

Next generation CAR with novel binding domain! Deep and durable response in high risk patients! Look forward to getting this to our patients! ⁦<a href="/MCWCancerCenter/">MCW Cancer Center</a>⁩ ⁦<a href="/EHA_Hematology/">European Hematology Association</a>⁩ #eha2024
Tom Martin (@tombmt133) 's Twitter Profile Photo

Perhaps the comeback kid of EHA - let’s SEE how toxicity can be mitigated- great presentations by Mari-vi and thanos 👍

Perhaps the comeback kid of EHA - let’s SEE how toxicity can be mitigated- great presentations by Mari-vi and thanos 👍
Tom Martin (@tombmt133) 's Twitter Profile Photo

M Raab - great job- updating GMMG-HD7 trial which will answer the question - but currently the MRD (-) rates are highest with before and after. Of note, this trial would have allowed accelerated approval of the quad based on MRD (based on FDA ODAC) but we are awaiting PFS

Tom Martin (@tombmt133) 's Twitter Profile Photo

Great collaboration between IMF and MSkCC, a great example for all of us to develop and encourage locally - need to reach all patients!

Tom Martin (@tombmt133) 's Twitter Profile Photo

Then @SOHO2024 at 8:00AM - join us for Supportive Care including an amazing CART case=> Dr Martin, MRD update with Dr Nooka and Maintenance with Dr CALLANDER - should be great

Tom Martin (@tombmt133) 's Twitter Profile Photo

Soho24 - and Wednesday 6:15PM will have our first MM Poster Walk - 4 posters - Perseus update (NDMM-TE), Iber-VD -new data (NDMM- TI), DREAMM-7 update RRMM, Mezi- triplet RRMM plus many excellent posters to view!!!! C ya there Society of Hematologic Oncology (SOHO)

Tom Martin (@tombmt133) 's Twitter Profile Photo

Hira Mian giving a great talk on frailty: need to stages the MM, and “stage the age” - the simplified faulty index (age, ECOG,CCI) can be done on everybody!!